2018
DOI: 10.1101/300822
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 33 publications
(46 reference statements)
0
1
0
Order By: Relevance
“…27 They also include beta-synuclein, which plays a detrimental role in Alzheimer's disease and Parkinson's disease. 28 Nevertheless, agents that have the potential to reduce excitotoxicity are currently under investigation as promising HIE therapies. 29…”
Section: Synaptic Proteinsmentioning
confidence: 99%
“…27 They also include beta-synuclein, which plays a detrimental role in Alzheimer's disease and Parkinson's disease. 28 Nevertheless, agents that have the potential to reduce excitotoxicity are currently under investigation as promising HIE therapies. 29…”
Section: Synaptic Proteinsmentioning
confidence: 99%